Could Roche’s Molecular Glue Deal Signal a New Drug Discovery Race?
Drug discovery in molecular glues gains momentum as Roche partners with Chinese company, Defand Therapeutics.
How Sensor-Enhanced Patient Data Completes the Story of the Trial
How much can clinical trials miss when researchers rely solely on patient-reported outcomes? Dr Helen Brooker, Director of Product and Clinical Data at Signant Health, joins Trisha Pillay to discuss how wearable sensors complement electronic clinical outcome assessments (eCOA).
Integrated Pharma Operations and Supply Chain Management
Pharma operations and supply chain management are converging with forecasting, manufacturing, resilience, and digitalisation of Technical Operations.
FDA’s AEMS Updated for Consolidated Adverse Event Monitoring
The FDA’s AEMS platform consolidates adverse event reporting beyond just integrating FAERS. Explore its impact on safety signals and pharmacovigilance.
AI in GMP Manufacturing: Are Regulators Ready for Digital Factories?
Learn how AI in pharmaceutical GMP manufacturing is improving quality, data integrity, predictive maintenance, and regulatory compliance in modern drug production.
Endpoints in Gynaecological Oncology Clinical Trials
Gynaecological oncology clinical trials reveal that survival gains and trial design do not always align. Here is what clinical development teams should learn.